CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 41426-41559 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T280","span":{"begin":0,"end":133},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Accordingly, serum anti-EBNA-1 IgG response seems to mark MS patients compared to other inflammatory and non inflammatory conditions."}

{"project":"Epistemic_Statements","denotations":[{"id":"T93","span":{"begin":0,"end":133},"obj":"Epistemic_statement"}],"text":"Accordingly, serum anti-EBNA-1 IgG response seems to mark MS patients compared to other inflammatory and non inflammatory conditions."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T280","span":{"begin":0,"end":133},"obj":"Sentence"}],"text":"Accordingly, serum anti-EBNA-1 IgG response seems to mark MS patients compared to other inflammatory and non inflammatory conditions."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T176","span":{"begin":13,"end":18},"obj":"Body_part"},{"id":"T177","span":{"begin":58,"end":60},"obj":"Body_part"}],"attributes":[{"id":"A176","pred":"uberon_id","subj":"T176","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"id":"A177","pred":"uberon_id","subj":"T177","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"}],"text":"Accordingly, serum anti-EBNA-1 IgG response seems to mark MS patients compared to other inflammatory and non inflammatory conditions."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T88153","span":{"begin":58,"end":60},"obj":"Disease"},{"id":"T28135","span":{"begin":58,"end":60},"obj":"Disease"}],"attributes":[{"id":"A47922","pred":"mondo_id","subj":"T88153","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A87011","pred":"mondo_id","subj":"T28135","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"}],"text":"Accordingly, serum anti-EBNA-1 IgG response seems to mark MS patients compared to other inflammatory and non inflammatory conditions."}